Vés al contingut

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Ralinepag to Evaluate Safety and Effects on Exercise Capacity Assessed by Cardiopulmonary Exercise Testing in Subjects with World Health Organization Group 1 Pulmonary Hypertension Who Recently Initiated Therapy (ADVANCE Capacity)

Obert
  • Codi protocol: ROR-PH-302
  • Codi EudraCT: 2019-003309-88
  • Grup de recerca: Pneumologia
  • Servei: Pneumologia
  • Investigador/a principal:  López Meseguer, Manuel
  • Malaltia: Malalties del sistema respiratori
  • Fase: Fase III